NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
28/07/2026
Voltar para busca
Dado oficial do USPTO
HELIXMITH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HELIXMITH
ST13
US500000088166343Classe
5, 35, 42
Pedido
88166343
Registro
5906698
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
28/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42
Data de depósito
23/10/2018
Data de registro
12/11/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/07/2026
Última transação
28/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Seoul, KR
Examinador
MAI, TINA HSIN
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Helixmith Co., Ltd
ViroMed Co., Ltd.
Representantes
Connie L. Ellerbach Fenwick & West LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
reagents for use in veterinary genetic testing for medical use; chemical preparations for pharmaceutical purposesfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; chemical preparations for use in DNA analysis for medical use; drugs for medical purposesfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; reagents for use in medical genetic testing for medical use; pharmaceutical drugsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; medicines for human purposesfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparationsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; therapeutic drugs and agentsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; biological preparationsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; crude medicinesfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; biological preparations for medical use in medical and clinical gene therapy and cell therapy; pharmaceutical preparationsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; biological preparations for medical usefor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer
Classe 35
Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agentsretail store services featuring biological preparations for medical use
Classe 42
Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information analysisgenetic testing for medical research purposes; biological information analysisgenetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research ; analysis of human tissues for medical research; blood analysis services
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
28/07/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/07/2026
E815
TEAS SECTION 8 & 15 RECEIVED
24/04/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/11/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
25/08/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/08/2020
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
19/02/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18/02/2020
XXXX
POST REGISTRATION ACTION CORRECTION
18/02/2020
WDRL
OTQR WITHDRAWAL FROM PUBLICATION
18/02/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
21/01/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21/01/2020
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/12/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/11/2019
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
06/10/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
19/06/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/06/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/05/2019
PUBO
PUBLISHED FOR OPPOSITION
28/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
22/04/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/04/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/04/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
03/04/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/03/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/03/2019
GNRT
NON-FINAL ACTION E-MAILED
22/03/2019
CNRT
NON-FINAL ACTION WRITTEN
22/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2019
ALIE
ASSIGNED TO LIE
08/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/01/2019
GNRT
NON-FINAL ACTION E-MAILED
05/01/2019
CNRT
NON-FINAL ACTION WRITTEN
05/01/2019
DOCK
ASSIGNED TO EXAMINER
03/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2018
NWAP
NEW APPLICATION ENTERED
26/10/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HELIXMITH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.